abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Diese Seite ist nicht auf Deutsch verfügbar und wird angezeigt auf English

Artikel

29 Jan 2018

Autor:
Jerry Mitchell, The (Jackson, Miss.) Clarion Ledger, USA Today

Opioid makers face hundreds of lawsuits for misleading doctors about drug’s addictive nature

The federal judge overseeing about 200 lawsuits against opioid makers would rather curb the opioid epidemic than referee the litigation...Opioid litigation...reached a flood last year when about 250 cities, counties and states sued opioid makers, wholesalers, distributors and marketers.  The lawsuits accuse the companies of misleading health care professionals and the public by marketing opioids as rarely addictive and a safe substitute for non-addictive pain medications, such as ibuprofen.  The companies deny the claims and say litigation should be halted until the Food and Drug Administration-ordered studies on the long-term risks and benefits of opioids are completed.  Experts say the sheer number of opioid lawsuits could lead some companies to settle...Some hospitals are suing, too...Every state attorney general has either filed a lawsuit against opioid makers or is involved in investigating whether these drugmakers misled health care providers about the addictiveness to opioids. 

 

Part of the following timelines

USA: New York City files lawsuit against opioid manufacturers & distributors in relation to deadly epidemic

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors